GLP-1 related hair changes have been reported in some studies, though the mechanism is not fully understood and may relate to caloric deficit rather than direct compound effects
Phase 1 Trials Phase 1 trials for Retatrutide primarily focused on: Establishing the safety and optimal dosage range of the drug Involving small groups of healthy volunteers who received varying doses of Retatrutide to identify the most effective and safe dosage levels Monitoring for any adverse effects, which were generally mild and manageable This initial phase was pivotal in laying the groundwork for subsequent efficacy trials, including a clinical trial
You found a compounding pharmacy, got your prescription, started your injections on schedule
PlexusDx eliminates insurance middlemen, requiring no membership fees and accepting HSA and FSA funds, making treatment accessible regardless of insurance status across all 50 states
Not a medicine, not evaluated by BPOM, and not for human or veterinary consumption